FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

4348911000001104: Dalacin C Phosphate 300mg/2ml solution for injection ampoules (Pfizer Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17912901000001111 Dalacin C Phosphate 300mg/2ml solution for injection ampoules (Pfizer Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17913001000001119 Dalacin C Phosphate 300mg/2ml solution for injection ampoules (Pfizer Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dalacin C Phosphate 300mg/2ml solution for injection ampoules (Pfizer Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Dalacin C Phosphate 300mg/2ml solution for injection ampoules (Pfizer Ltd) Is a Clindamycin 300mg/2mL injection false Inferred relationship Existential restriction modifier
Dalacin C Phosphate 300mg/2ml solution for injection ampoules (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Dalacin C Phosphate 300mg/2ml solution for injection ampoules (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Dalacin C Phosphate 300mg/2ml solution for injection ampoules (Pfizer Ltd) Has excipient Benzyl alcohol false Inferred relationship Existential restriction modifier
Dalacin C Phosphate 300mg/2ml solution for injection ampoules (Pfizer Ltd) Has active ingredient Bactericide false Inferred relationship Existential restriction modifier
Dalacin C Phosphate 300mg/2ml solution for injection ampoules (Pfizer Ltd) Has active ingredient Clindamycin phosphate true Inferred relationship Existential restriction modifier
Dalacin C Phosphate 300mg/2ml solution for injection ampoules (Pfizer Ltd) Has excipient Edetate disodium false Inferred relationship Existential restriction modifier
Dalacin C Phosphate 300mg/2ml solution for injection ampoules (Pfizer Ltd) Has active ingredient Substance with antibacterial mechanism of action false Inferred relationship Existential restriction modifier
Dalacin C Phosphate 300mg/2ml solution for injection ampoules (Pfizer Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Dalacin C Phosphate 300mg/2ml solution for injection ampoules (Pfizer Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Dalacin C Phosphate 300mg/2ml solution for injection ampoules (Pfizer Ltd) Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
Dalacin C Phosphate 300mg/2ml solution for injection ampoules (Pfizer Ltd) Is a Dalacin C true Inferred relationship Existential restriction modifier
Dalacin C Phosphate 300mg/2ml solution for injection ampoules (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Clindamycin true Inferred relationship Existential restriction modifier
Dalacin C Phosphate 300mg/2ml solution for injection ampoules (Pfizer Ltd) Has specific active ingredient Clindamycin phosphate true Inferred relationship Existential restriction modifier
Dalacin C Phosphate 300mg/2ml solution for injection ampoules (Pfizer Ltd) Has dispensed dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Dalacin C Phosphate 300mg/2ml solution for injection ampoules (Pfizer Ltd) Has manufactured dose form Injection false Inferred relationship Existential restriction modifier
Dalacin C Phosphate 300mg/2ml solution for injection ampoules (Pfizer Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Dalacin C Phosphate 300mg/2ml solution for injection ampoules (Pfizer Ltd) Has basis of strength substance Clindamycin true Inferred relationship Existential restriction modifier
Dalacin C Phosphate 300mg/2ml solution for injection ampoules (Pfizer Ltd) Is a Clindamycin 300mg/2ml solution for injection ampoules false Inferred relationship Existential restriction modifier
Dalacin C Phosphate 300mg/2ml solution for injection ampoules (Pfizer Ltd) Is a Clindamycin 300mg/2ml solution for injection ampoules true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Dalacin C Phosphate 300mg/2ml solution for injection ampoules (Pfizer Ltd) 5 ampoule 5 x 2ml ampoules Is pack of False Dalacin C Phosphate 300mg/2ml solution for injection ampoules (Pfizer Ltd) Inferred relationship Existential restriction modifier
Dalacin C Phosphate 300mg/2ml solution for injection ampoules (Pfizer Ltd) 5 ampoule 5 x 2ml ampoules Has AMP True Dalacin C Phosphate 300mg/2ml solution for injection ampoules (Pfizer Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start